411 related articles for article (PubMed ID: 22183133)
1. α-Tocopherol succinate-modified chitosan as a micellar delivery system for paclitaxel: preparation, characterization and in vitro/in vivo evaluations.
Liang N; Sun S; Li X; Piao H; Piao H; Cui F; Fang L
Int J Pharm; 2012 Feb; 423(2):480-8. PubMed ID: 22183133
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and characterization of low-toxic amphiphilic chitosan derivatives and their application as micelle carrier for antitumor drug.
Huo M; Zhang Y; Zhou J; Zou A; Yu D; Wu Y; Li J; Li H
Int J Pharm; 2010 Jul; 394(1-2):162-73. PubMed ID: 20457237
[TBL] [Abstract][Full Text] [Related]
3. In vivo pharmacokinetics, biodistribution and antitumor effect of paclitaxel-loaded micelles based on α-tocopherol succinate-modified chitosan.
Liang N; Sun S; Hong J; Tian J; Fang L; Cui F
Drug Deliv; 2016 Oct; 23(8):2651-2660. PubMed ID: 26165423
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterization of a novel polydepsipeptide contained tri-block copolymer (mPEG-PLLA-PMMD) as self-assembly micelle delivery system for paclitaxel.
Zhao Y; Li J; Yu H; Wang G; Liu W
Int J Pharm; 2012 Jul; 430(1-2):282-91. PubMed ID: 22484705
[TBL] [Abstract][Full Text] [Related]
5. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
6. Self-assembly and characterization of paclitaxel-loaded N-octyl-O-sulfate chitosan micellar system.
Zhang C; Qineng P; Zhang H
Colloids Surf B Biointerfaces; 2004 Nov; 39(1-2):69-75. PubMed ID: 15542343
[TBL] [Abstract][Full Text] [Related]
7. Tocol modified glycol chitosan for the oral delivery of poorly soluble drugs.
Duhem N; Rolland J; Riva R; Guillet P; Schumers JM; Jérome C; Gohy JF; Préat V
Int J Pharm; 2012 Feb; 423(2):452-60. PubMed ID: 22212463
[TBL] [Abstract][Full Text] [Related]
8. [Solubilizing and sustained-releasing abilities and safety preliminary evaluation for paclitaxel based on N-octyl-O, N-carboxymethyl chitosan polymeric micelles].
Huo MR; Zhang Y; Zhou JP; Lü L; Liu H; Liu FJ
Yao Xue Xue Bao; 2008 Aug; 43(8):855-61. PubMed ID: 18956780
[TBL] [Abstract][Full Text] [Related]
9. PEG conjugated N-octyl-O-sulfate chitosan micelles for delivery of paclitaxel: in vitro characterization and in vivo evaluation.
Qu G; Yao Z; Zhang C; Wu X; Ping Q
Eur J Pharm Sci; 2009 May; 37(2):98-105. PubMed ID: 19429416
[TBL] [Abstract][Full Text] [Related]
10. Amphiphilic Polymeric Micelles Based on Deoxycholic Acid and Folic Acid Modified Chitosan for the Delivery of Paclitaxel.
Li L; Liang N; Wang D; Yan P; Kawashima Y; Cui F; Sun S
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30322014
[TBL] [Abstract][Full Text] [Related]
11. Encapsulation of paclitaxel into lauric acid-O-carboxymethyl chitosan-transferrin micelles for hydrophobic drug delivery and site-specific targeted delivery.
Nam JP; Park SC; Kim TH; Jang JY; Choi C; Jang MK; Nah JW
Int J Pharm; 2013 Nov; 457(1):124-35. PubMed ID: 24076228
[TBL] [Abstract][Full Text] [Related]
12. Polymeric Micelles Based on Modified Glycol Chitosan for Paclitaxel Delivery: Preparation, Characterization and Evaluation.
Liang N; Sun S; Gong X; Li Q; Yan P; Cui F
Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29882845
[TBL] [Abstract][Full Text] [Related]
13. New self-assembling polyaspartylhydrazide copolymer micelles for anticancer drug delivery.
Licciardi M; Cavallaro G; Di Stefano M; Pitarresi G; Fiorica C; Giammona G
Int J Pharm; 2010 Aug; 396(1-2):219-28. PubMed ID: 20600731
[TBL] [Abstract][Full Text] [Related]
14. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery.
Soga O; van Nostrum CF; Fens M; Rijcken CJ; Schiffelers RM; Storm G; Hennink WE
J Control Release; 2005 Mar; 103(2):341-53. PubMed ID: 15763618
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of paclitaxel and α-tocopherol succinate by novel chitosan-based polymeric micelles for improving micellar stability and efficacious combination therapy.
Emami J; Rezazadeh M; Rostami M; Hassanzadeh F; Sadeghi H; Mostafavi A; Minaiyan M; Lavasanifar A
Drug Dev Ind Pharm; 2015; 41(7):1137-47. PubMed ID: 25019502
[TBL] [Abstract][Full Text] [Related]
16. Tissue distribution and pharmacokinetics evaluation of DOMC-FA micelles for intravenous delivery of PTX.
Wang F; Zhang D; Zhang Q; Guo S; Zheng D; Hao L; Guo H; Li C
J Drug Target; 2013 Feb; 21(2):137-45. PubMed ID: 23046502
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of amphiphilic chitosan derivatives as a nano-carrier for paclitaxel delivery.
Zhou H; Liu X; Guo X; Li N; Yu W; Zhang Y; Ma X
J Control Release; 2011 Nov; 152 Suppl 1():e124-5. PubMed ID: 22195795
[No Abstract] [Full Text] [Related]
18. Tocopheryl succinate-based lipid nanospheres for paclitaxel delivery: preparation, characters, and in vitro release kinetics.
Shi K; Jiang Y; Zhang M; Wang Y; Cui F
Drug Deliv; 2010 Jan; 17(1):1-10. PubMed ID: 19941405
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization, drug-loading capacity and safety of novel octyl modified serum albumin micelles.
Gong J; Huo M; Zhou J; Zhang Y; Peng X; Yu D; Zhang H; Li J
Int J Pharm; 2009 Jul; 376(1-2):161-8. PubMed ID: 19409461
[TBL] [Abstract][Full Text] [Related]
20. Amphiphilic N-(2,3-dihydroxypropyl)-chitosan-cholic acid micelles for paclitaxel delivery.
Pan Z; Gao Y; Heng L; Liu Y; Yao G; Wang Y; Liu Y
Carbohydr Polym; 2013 Apr; 94(1):394-9. PubMed ID: 23544554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
